Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Rugo HS, Diéras V, Gelmon KA, Finn RS, Slamon DJ, Martin M, Neven P, Shparyk Y, Mori A, Lu DR, Bhattacharyya H, Bartlett CHUANG, Iyer S, Johnston S, Ettl J, Harbeck N

Publication

Annals of oncology : official journal of the European Society for Medical Oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1412238

Publication Year

2018

PubMed ID

29360932

Publication Title

Rugo HS, Diéras V, Gelmon KA, Finn RS, Slamon DJ, Martin M, Neven P, Shparyk Y, Mori A, Lu DR, Bhattacharyya H, Bartlett CHUANG, Iyer S, Johnston S, Ettl J, Harbeck N. Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. Ann Oncol. 2018 04 01; 29(4):888-894.